menu
    • menu

    Company profile for Sunrise Pharmaceutical Inc

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Sunrise Pharmaceutical, Inc. is a U.S manufacturer of generic pharmaceutical products in solid dosage forms. Our focus is to develop products that offer niche opportunities within the OTC and generic drug markets. With a total commitment to quality and service, we are strategically positioned to meet and exceed expectations of our customers. Our facility is fully cGMP compliant and FDA registered.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Sunrise Pharmaceutical IncUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Sunrise Pharmaceutical, Inc., 665 East Lincoln Ave, Rahway NJ, 07065, US
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://sunrisepharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sunrise Generic Chlordiazepoxide HCL; Clidinium bromide Receives Approval In US
    Sunrise Generic Chlordiazepoxide HCL; Clidinium bromide Receives Approval In US

    10 Jul 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211421

    FDA
    10 Jul 2020
    Share Share
    A wave of drug recalls hits Indian pharma firms in US
    A wave of drug recalls hits Indian pharma firms in US

    09 Jan 2019

    // DNA INDIA

    https://www.dnaindia.com/business/report-a-wave-of-drug-recalls-hits-indian-pharma-firms-in-us-2705817

    DNA INDIA
    09 Jan 2019
    Share Share
    Sebi examining whistleblower complaint against Sun Pharma
    Sebi examining whistleblower complaint against Sun Pharma

    13 Dec 2018

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/markets/stocks/news/sebi-examining-whistleblower-complaint-against-sun-pharma/articleshow/67070064.cms

    ECONOMIC TIMES
    13 Dec 2018
    Share Share
    Sunrise Pharm's Generic Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Receives Approval In US
    Sunrise Pharm's Generic Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Receives Approval In US

    30 Dec 2017

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209799

    FDA
    30 Dec 2017
    Share Share
    Sunrise Pharmaceutical Generic Dextroamphetamine Sulfate Receives Approval In US
    Sunrise Pharmaceutical Generic Dextroamphetamine Sulfate Receives Approval In US

    23 Oct 2017

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210059

    FDA
    23 Oct 2017
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search